Development and validation of a hierarchical machine learning method using MALDI-TOF mass spectrometry for rapid SCCmec typing and PVL detection in MRSA: a multi-centre study

Abstract

Objectives Methicillin-resistant Staphylococcus aureus (MRSA) is a major public health concern because of its genotypic diversity and association with severe infections, particularly those caused by strains carrying Panton–Valentine leukocidin (PVL). This study aimed to develop an artificial intelligence-clinical decision support system (AI-CDSS) to streamline MRSA genotyping and PVL detection, providing a more efficient alternative to complex PCR-based workflows.Methods We retrospectively analysed 345,748 bacterial specimens collected from five healthcare institutions between 2010 and 2024. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry data were analysed using a hierarchical classification framework enhanced by machine learning models to identify the MRSA status, staphylococcal cassette chromosome mec subtypes, and PVL presence. Area under the curve (AUC), sensitivity, and specificity were used for model evaluation.Results AI-CDSS was highly accurate for MRSA genotyping (AUCs > 0.9) and PVL detection (AUC = 0.85). Automating hierarchical classifications effectively replaced labour-intensive PCR processes, reducing diagnostic complexity and resource use.Conclusions AI-CDSS is a scalable and efficient method for MRSA genotyping and PVL detection. By streamlining diagnostics and supporting timely clinical interventions, this system can improve infection management and patient care, which will reduce mortality associated with MRSA infections.

Keywords

• MRSA
• PVL
• artificial intelligence
• artificial intelligence-clinical decision support systems
• AI-CDSS